Company · CIK 0000875320 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
VERTEX PHARMACEUTICALS INC / MA · VRTX
Insider activity reported against this company. All insider holders · Files at: CRSP. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 AForm 4 → | Sep 10, 4:31 pm EDT | Jasper van GrunsvenEVP, CP and NPPO | 8,682 | — | — | 8,682 | — | |
| Aug 28, 2026 AForm 4 → | Sep 1, 4:39 pm EDT | Kristen AmbroseSVP & Chief Accounting Officer | 5,000 | — | — | 11,624 | — | |
| Aug 27, 2026 GForm 4 → | Aug 31, 4:20 pm EDT | Bruce I SachsDirector | 6,000 | — | — | 39,000 | — | |
| Jul 21, 2026 AForm 4 → | Jul 23, 4:15 pm EDT | Ourania TatsisEVP, Chief Reg. & Quality Off. | 8,251 | — | — | 53,572 | — | |
| Jul 21, 2026 AForm 4 → | Jul 23, 4:13 pm EDT | Amit SachdevEVP Chief Patient & Ext Af Off | 8,251 | — | — | 66,512 | — | |
| Jul 2, 2026 SForm 4 → | Jul 7, 4:15 pm EDT | Ourania TatsisEVP, Chief Reg. & Quality Off. | 1,500 | $524.99 | $787,485 | 45,321 | −3.20% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 7, 4:08 pm EDT | Duncan McKechnieEVP, Chief Commercial Officer | 1,541 | $519.00 | $799,779 | 11,001 | −12.3% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 4:13 pm EDT | Joy LiuEVP and Chief Legal Officer | 828 | $502.71 | $416,244 | 19,131 | −4.15% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 AForm 4 → | Jul 17, 4:06 pm EDT | Bruce I SachsDirector | 100 | $475.28 | $47,500 | 15,772 | — | |
| Jul 15, 2026 AForm 4 → | Jul 17, 4:05 pm EDT | Alan M GarberDirector | 32 | $475.28 | $15,000 | 65 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.